A retrospective study of 106 patients with muscle-invasive bladder cancer (MIBC) has shown that tumour budding is an independent predictor of cancer-specific mortality. Tumour buds were identified and quantified on radical cystectomy samples using the hot-spot method. Mean tumour bud count was 32.3 ± 25.9 buds, with 14 buds being the cut-off point according to the receiver operating characteristic. Mean survival for participants with ≤14 buds was 65.9 months, but survival for those with >14 buds was only 18.5 months (P = 0.003). In multivariable analysis, number of tumour buds was an independent predictor of mortality. Patients with >14 buds had a 2.27-fold increased risk of mortality and the risk of mortality increased progressively with the number of buds at a rate of 2% per bud. Thus, tumour budding could be used as a predictor of cancer-specific mortality in patients with MIBC.
References
Original article
Lorenzo Soriano, L. et al. Tumor budding: prognostic value in muscle-invasive bladder cancer. Urology https://doi.org/10.1016/j.urology.2019.04.006 (2019)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Stone, L. Budding prognostic technique for muscle-invasive bladder cancer. Nat Rev Urol 16, 330 (2019). https://doi.org/10.1038/s41585-019-0187-1
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41585-019-0187-1